Influencing Receptor−Ligand Binding Mechanisms with Multivalent Ligand Architecture

Multivalent ligands can function as inhibitors or effectors of biological processes. Potent inhibitory activity can arise from the high functional affinities of multivalent ligand−receptor interactions. Effector functions, however, are influenced not only by apparent affinities but also by alternate...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American Chemical Society 2002-12, Vol.124 (50), p.14922-14933
Hauptverfasser: Gestwicki, Jason E, Cairo, Christopher W, Strong, Laura E, Oetjen, Karolyn A, Kiessling, Laura L
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 14933
container_issue 50
container_start_page 14922
container_title Journal of the American Chemical Society
container_volume 124
creator Gestwicki, Jason E
Cairo, Christopher W
Strong, Laura E
Oetjen, Karolyn A
Kiessling, Laura L
description Multivalent ligands can function as inhibitors or effectors of biological processes. Potent inhibitory activity can arise from the high functional affinities of multivalent ligand−receptor interactions. Effector functions, however, are influenced not only by apparent affinities but also by alternate factors, including the ability of a ligand to cluster receptors. Little is known about the molecular features of a multivalent ligand that determine whether it will function as an inhibitor or effector. We envisioned that, by altering multivalent ligand architecture, ligands with preferences for different binding mechanisms would be generated. To this end, a series of 28 ligands possessing structural diversity was synthesized. This series provides the means to explore the effects of ligand architecture on the inhibition and clustering of a model protein, the lectin concanavalin A (Con A). The structural parameters that were varied include scaffold shape, size, valency, and density of binding elements. We found that ligands with certain architectures are effective inhibitors, but others mediate receptor clustering. Specifically, high molecular weight, polydisperse polyvalent ligands are effective inhibitors of Con A binding, whereas linear oligomeric ligands generated by the ring-opening metathesis polymerization have structural properties that favor clustering. The shape of a multivalent ligand also influences specific aspects of receptor clustering. These include the rate at which the receptor is clustered, the number of receptors in the clusters, and the average interreceptor distance. Our results indicate that the architecture of a multivalent ligand is a key parameter in determining its activity as an inhibitor or effector. Diversity-oriented syntheses of multivalent ligands coupled with effective assays that can be used to compare the contributions of different binding parameters may afford ligands that function by specific mechanisms.
doi_str_mv 10.1021/ja027184x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72760198</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72760198</sourcerecordid><originalsourceid>FETCH-LOGICAL-a379t-6f23eeb360b0299e213350ae1032b35301e6c032d9bd6dc563b9f3aaadd04acb3</originalsourceid><addsrcrecordid>eNpt0MFu1DAQBmALgehSOPACKBeQOKTYnthJjqWitNIWELTiaE2cSddL1llsB8ob9Mwj8iRNtVH3wsljzadfo5-xl4IfCS7FuzVyWYqquHnEFkJJnish9WO24JzLvKw0HLBnMa6nbyEr8ZQdCFmUCqBYsKtz3_Ujeev8dfaVLG3TEP7d_l26a_Rt9t759n5zQXaF3sVNzH67tMouxj65X9iTT9lMj4NduUQ2jYGesycd9pFezO8huzr9cHlyli8_fzw_OV7mCGWdct1JIGpA84bLuiYpABRHEhxkAwq4IG2nua2bVrdWaWjqDhCxbXmBtoFD9maXuw3Dz5FiMhsXLfU9ehrGaEpZai7qaoJvd9CGIcZAndkGt8Hwxwhu7js0Dx1O9tUcOjYbavdyLm0Cr2eA0WLfBZzqi3tXVLWSQk4u3zkXE9087DH8MLqEUpnLL9_MdwFLdQqfjNrnoo1mPYzBT93958A7Uz6Vgw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72760198</pqid></control><display><type>article</type><title>Influencing Receptor−Ligand Binding Mechanisms with Multivalent Ligand Architecture</title><source>ACS Publications</source><source>MEDLINE</source><creator>Gestwicki, Jason E ; Cairo, Christopher W ; Strong, Laura E ; Oetjen, Karolyn A ; Kiessling, Laura L</creator><creatorcontrib>Gestwicki, Jason E ; Cairo, Christopher W ; Strong, Laura E ; Oetjen, Karolyn A ; Kiessling, Laura L</creatorcontrib><description>Multivalent ligands can function as inhibitors or effectors of biological processes. Potent inhibitory activity can arise from the high functional affinities of multivalent ligand−receptor interactions. Effector functions, however, are influenced not only by apparent affinities but also by alternate factors, including the ability of a ligand to cluster receptors. Little is known about the molecular features of a multivalent ligand that determine whether it will function as an inhibitor or effector. We envisioned that, by altering multivalent ligand architecture, ligands with preferences for different binding mechanisms would be generated. To this end, a series of 28 ligands possessing structural diversity was synthesized. This series provides the means to explore the effects of ligand architecture on the inhibition and clustering of a model protein, the lectin concanavalin A (Con A). The structural parameters that were varied include scaffold shape, size, valency, and density of binding elements. We found that ligands with certain architectures are effective inhibitors, but others mediate receptor clustering. Specifically, high molecular weight, polydisperse polyvalent ligands are effective inhibitors of Con A binding, whereas linear oligomeric ligands generated by the ring-opening metathesis polymerization have structural properties that favor clustering. The shape of a multivalent ligand also influences specific aspects of receptor clustering. These include the rate at which the receptor is clustered, the number of receptors in the clusters, and the average interreceptor distance. Our results indicate that the architecture of a multivalent ligand is a key parameter in determining its activity as an inhibitor or effector. Diversity-oriented syntheses of multivalent ligands coupled with effective assays that can be used to compare the contributions of different binding parameters may afford ligands that function by specific mechanisms.</description><identifier>ISSN: 0002-7863</identifier><identifier>EISSN: 1520-5126</identifier><identifier>DOI: 10.1021/ja027184x</identifier><identifier>PMID: 12475334</identifier><identifier>CODEN: JACSAT</identifier><language>eng</language><publisher>Washington, DC: American Chemical Society</publisher><subject>Biological and medical sciences ; Chemical Precipitation ; Chemistry ; Concanavalin A - antagonists &amp; inhibitors ; Concanavalin A - chemistry ; Concanavalin A - metabolism ; Exact sciences and technology ; Fundamental and applied biological sciences. Psychology ; General and physical chemistry ; Interactions. Associations ; Intermolecular phenomena ; Ligands ; Models, Molecular ; Molecular biophysics ; Molecular Weight ; Polymers - chemistry ; Receptors, Cell Surface - antagonists &amp; inhibitors ; Receptors, Cell Surface - chemistry ; Receptors, Cell Surface - metabolism ; Serum Albumin, Bovine - antagonists &amp; inhibitors ; Serum Albumin, Bovine - chemistry ; Serum Albumin, Bovine - metabolism ; Solution properties ; Solutions</subject><ispartof>Journal of the American Chemical Society, 2002-12, Vol.124 (50), p.14922-14933</ispartof><rights>Copyright © 2002 American Chemical Society</rights><rights>2003 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a379t-6f23eeb360b0299e213350ae1032b35301e6c032d9bd6dc563b9f3aaadd04acb3</citedby><cites>FETCH-LOGICAL-a379t-6f23eeb360b0299e213350ae1032b35301e6c032d9bd6dc563b9f3aaadd04acb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/ja027184x$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/ja027184x$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,776,780,2752,27053,27901,27902,56713,56763</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14895212$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12475334$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gestwicki, Jason E</creatorcontrib><creatorcontrib>Cairo, Christopher W</creatorcontrib><creatorcontrib>Strong, Laura E</creatorcontrib><creatorcontrib>Oetjen, Karolyn A</creatorcontrib><creatorcontrib>Kiessling, Laura L</creatorcontrib><title>Influencing Receptor−Ligand Binding Mechanisms with Multivalent Ligand Architecture</title><title>Journal of the American Chemical Society</title><addtitle>J. Am. Chem. Soc</addtitle><description>Multivalent ligands can function as inhibitors or effectors of biological processes. Potent inhibitory activity can arise from the high functional affinities of multivalent ligand−receptor interactions. Effector functions, however, are influenced not only by apparent affinities but also by alternate factors, including the ability of a ligand to cluster receptors. Little is known about the molecular features of a multivalent ligand that determine whether it will function as an inhibitor or effector. We envisioned that, by altering multivalent ligand architecture, ligands with preferences for different binding mechanisms would be generated. To this end, a series of 28 ligands possessing structural diversity was synthesized. This series provides the means to explore the effects of ligand architecture on the inhibition and clustering of a model protein, the lectin concanavalin A (Con A). The structural parameters that were varied include scaffold shape, size, valency, and density of binding elements. We found that ligands with certain architectures are effective inhibitors, but others mediate receptor clustering. Specifically, high molecular weight, polydisperse polyvalent ligands are effective inhibitors of Con A binding, whereas linear oligomeric ligands generated by the ring-opening metathesis polymerization have structural properties that favor clustering. The shape of a multivalent ligand also influences specific aspects of receptor clustering. These include the rate at which the receptor is clustered, the number of receptors in the clusters, and the average interreceptor distance. Our results indicate that the architecture of a multivalent ligand is a key parameter in determining its activity as an inhibitor or effector. Diversity-oriented syntheses of multivalent ligands coupled with effective assays that can be used to compare the contributions of different binding parameters may afford ligands that function by specific mechanisms.</description><subject>Biological and medical sciences</subject><subject>Chemical Precipitation</subject><subject>Chemistry</subject><subject>Concanavalin A - antagonists &amp; inhibitors</subject><subject>Concanavalin A - chemistry</subject><subject>Concanavalin A - metabolism</subject><subject>Exact sciences and technology</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>General and physical chemistry</subject><subject>Interactions. Associations</subject><subject>Intermolecular phenomena</subject><subject>Ligands</subject><subject>Models, Molecular</subject><subject>Molecular biophysics</subject><subject>Molecular Weight</subject><subject>Polymers - chemistry</subject><subject>Receptors, Cell Surface - antagonists &amp; inhibitors</subject><subject>Receptors, Cell Surface - chemistry</subject><subject>Receptors, Cell Surface - metabolism</subject><subject>Serum Albumin, Bovine - antagonists &amp; inhibitors</subject><subject>Serum Albumin, Bovine - chemistry</subject><subject>Serum Albumin, Bovine - metabolism</subject><subject>Solution properties</subject><subject>Solutions</subject><issn>0002-7863</issn><issn>1520-5126</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpt0MFu1DAQBmALgehSOPACKBeQOKTYnthJjqWitNIWELTiaE2cSddL1llsB8ob9Mwj8iRNtVH3wsljzadfo5-xl4IfCS7FuzVyWYqquHnEFkJJnish9WO24JzLvKw0HLBnMa6nbyEr8ZQdCFmUCqBYsKtz3_Ujeev8dfaVLG3TEP7d_l26a_Rt9t759n5zQXaF3sVNzH67tMouxj65X9iTT9lMj4NduUQ2jYGesycd9pFezO8huzr9cHlyli8_fzw_OV7mCGWdct1JIGpA84bLuiYpABRHEhxkAwq4IG2nua2bVrdWaWjqDhCxbXmBtoFD9maXuw3Dz5FiMhsXLfU9ehrGaEpZai7qaoJvd9CGIcZAndkGt8Hwxwhu7js0Dx1O9tUcOjYbavdyLm0Cr2eA0WLfBZzqi3tXVLWSQk4u3zkXE9087DH8MLqEUpnLL9_MdwFLdQqfjNrnoo1mPYzBT93958A7Uz6Vgw</recordid><startdate>20021218</startdate><enddate>20021218</enddate><creator>Gestwicki, Jason E</creator><creator>Cairo, Christopher W</creator><creator>Strong, Laura E</creator><creator>Oetjen, Karolyn A</creator><creator>Kiessling, Laura L</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20021218</creationdate><title>Influencing Receptor−Ligand Binding Mechanisms with Multivalent Ligand Architecture</title><author>Gestwicki, Jason E ; Cairo, Christopher W ; Strong, Laura E ; Oetjen, Karolyn A ; Kiessling, Laura L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a379t-6f23eeb360b0299e213350ae1032b35301e6c032d9bd6dc563b9f3aaadd04acb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Biological and medical sciences</topic><topic>Chemical Precipitation</topic><topic>Chemistry</topic><topic>Concanavalin A - antagonists &amp; inhibitors</topic><topic>Concanavalin A - chemistry</topic><topic>Concanavalin A - metabolism</topic><topic>Exact sciences and technology</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>General and physical chemistry</topic><topic>Interactions. Associations</topic><topic>Intermolecular phenomena</topic><topic>Ligands</topic><topic>Models, Molecular</topic><topic>Molecular biophysics</topic><topic>Molecular Weight</topic><topic>Polymers - chemistry</topic><topic>Receptors, Cell Surface - antagonists &amp; inhibitors</topic><topic>Receptors, Cell Surface - chemistry</topic><topic>Receptors, Cell Surface - metabolism</topic><topic>Serum Albumin, Bovine - antagonists &amp; inhibitors</topic><topic>Serum Albumin, Bovine - chemistry</topic><topic>Serum Albumin, Bovine - metabolism</topic><topic>Solution properties</topic><topic>Solutions</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gestwicki, Jason E</creatorcontrib><creatorcontrib>Cairo, Christopher W</creatorcontrib><creatorcontrib>Strong, Laura E</creatorcontrib><creatorcontrib>Oetjen, Karolyn A</creatorcontrib><creatorcontrib>Kiessling, Laura L</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American Chemical Society</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gestwicki, Jason E</au><au>Cairo, Christopher W</au><au>Strong, Laura E</au><au>Oetjen, Karolyn A</au><au>Kiessling, Laura L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Influencing Receptor−Ligand Binding Mechanisms with Multivalent Ligand Architecture</atitle><jtitle>Journal of the American Chemical Society</jtitle><addtitle>J. Am. Chem. Soc</addtitle><date>2002-12-18</date><risdate>2002</risdate><volume>124</volume><issue>50</issue><spage>14922</spage><epage>14933</epage><pages>14922-14933</pages><issn>0002-7863</issn><eissn>1520-5126</eissn><coden>JACSAT</coden><abstract>Multivalent ligands can function as inhibitors or effectors of biological processes. Potent inhibitory activity can arise from the high functional affinities of multivalent ligand−receptor interactions. Effector functions, however, are influenced not only by apparent affinities but also by alternate factors, including the ability of a ligand to cluster receptors. Little is known about the molecular features of a multivalent ligand that determine whether it will function as an inhibitor or effector. We envisioned that, by altering multivalent ligand architecture, ligands with preferences for different binding mechanisms would be generated. To this end, a series of 28 ligands possessing structural diversity was synthesized. This series provides the means to explore the effects of ligand architecture on the inhibition and clustering of a model protein, the lectin concanavalin A (Con A). The structural parameters that were varied include scaffold shape, size, valency, and density of binding elements. We found that ligands with certain architectures are effective inhibitors, but others mediate receptor clustering. Specifically, high molecular weight, polydisperse polyvalent ligands are effective inhibitors of Con A binding, whereas linear oligomeric ligands generated by the ring-opening metathesis polymerization have structural properties that favor clustering. The shape of a multivalent ligand also influences specific aspects of receptor clustering. These include the rate at which the receptor is clustered, the number of receptors in the clusters, and the average interreceptor distance. Our results indicate that the architecture of a multivalent ligand is a key parameter in determining its activity as an inhibitor or effector. Diversity-oriented syntheses of multivalent ligands coupled with effective assays that can be used to compare the contributions of different binding parameters may afford ligands that function by specific mechanisms.</abstract><cop>Washington, DC</cop><pub>American Chemical Society</pub><pmid>12475334</pmid><doi>10.1021/ja027184x</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0002-7863
ispartof Journal of the American Chemical Society, 2002-12, Vol.124 (50), p.14922-14933
issn 0002-7863
1520-5126
language eng
recordid cdi_proquest_miscellaneous_72760198
source ACS Publications; MEDLINE
subjects Biological and medical sciences
Chemical Precipitation
Chemistry
Concanavalin A - antagonists & inhibitors
Concanavalin A - chemistry
Concanavalin A - metabolism
Exact sciences and technology
Fundamental and applied biological sciences. Psychology
General and physical chemistry
Interactions. Associations
Intermolecular phenomena
Ligands
Models, Molecular
Molecular biophysics
Molecular Weight
Polymers - chemistry
Receptors, Cell Surface - antagonists & inhibitors
Receptors, Cell Surface - chemistry
Receptors, Cell Surface - metabolism
Serum Albumin, Bovine - antagonists & inhibitors
Serum Albumin, Bovine - chemistry
Serum Albumin, Bovine - metabolism
Solution properties
Solutions
title Influencing Receptor−Ligand Binding Mechanisms with Multivalent Ligand Architecture
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T15%3A28%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Influencing%20Receptor%E2%88%92Ligand%20Binding%20Mechanisms%20with%20Multivalent%20Ligand%20Architecture&rft.jtitle=Journal%20of%20the%20American%20Chemical%20Society&rft.au=Gestwicki,%20Jason%20E&rft.date=2002-12-18&rft.volume=124&rft.issue=50&rft.spage=14922&rft.epage=14933&rft.pages=14922-14933&rft.issn=0002-7863&rft.eissn=1520-5126&rft.coden=JACSAT&rft_id=info:doi/10.1021/ja027184x&rft_dat=%3Cproquest_cross%3E72760198%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72760198&rft_id=info:pmid/12475334&rfr_iscdi=true